Page 98 - EASL POSTGRADUATE COURSE
P. 98
References
[1] Angulo P.The Natural History of NAFLD. In: Farrell GC, McCullough AJ, C.P. D, editors. Non-
Alcoholic Fatty Liver Disease: A Practical Guide. London: Wiley Blackwell Press 2013. p. 37-45.
[2] Ekstedt M, Franzen LE, Mathiesen UL, et al. Long-term follow-up of patients with NAFLD and
elevated liver enzymes. Hepatology 2006;44:865-873.
[3] Soderberg C, Stal P, Askling J, et al. Decreased survival of subjects with elevated liver function
tests during a 28-year follow-up. Hepatology 2010;51:595-602.
[4] Younossi ZM, Stepanova M, Rafiq N, et al. Pathologic criteria for nonalcoholic steatohepatitis:
interprotocol agreement and ability to predict liver-related mortality. Hepatology 2011;53:1874-
1882.
[5] Angulo P, Bugianesi E, Bjornsson ES, et al. Simple noninvasive systems predict long-term
outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology 2013;145:782-789
e784.
[6] Singh S, Allen AM, Wang Z, et al. Fibrosis Progression in Nonalcoholic Fatty Liver vs
Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis of Paired-Biopsy Studies.
Clin Gastroenterol Hepatol 2014; doi: 10.1016/j.cgh.2014.04.014.
[7] McPherson S, Hardy T, Henderson E, et al. Evidence of NAFLD progression from steatosis to
fibrosing-steatohepatitis using paired biopsies: implications for prognosis & clinical management.
J Hepatol 2014; doi: 10.1016/j.jhep.2014.11.034.
[8] Pais R, Charlotte F, Fedchuk L, et al. A systematic review of follow-up biopsies reveals disease
progression in patients with non-alcoholic fatty liver. J Hepatol 2013;59:550-556.
[9] Adams LA, Sanderson S, Lindor KD, et al. The histological course of nonalcoholic fatty liver
disease: a longitudinal study of 103 patients with sequential liver biopsies. J Hepatol 2005;42:132-
138.
[10] Anstee QM, Day CP.The genetics of NAFLD. Nat Rev Gastroenterol Hepatol 2013;10:645-655.
98 Postgraduate Course Syllabus • Metabolic Liver Disease
[1] Angulo P.The Natural History of NAFLD. In: Farrell GC, McCullough AJ, C.P. D, editors. Non-
Alcoholic Fatty Liver Disease: A Practical Guide. London: Wiley Blackwell Press 2013. p. 37-45.
[2] Ekstedt M, Franzen LE, Mathiesen UL, et al. Long-term follow-up of patients with NAFLD and
elevated liver enzymes. Hepatology 2006;44:865-873.
[3] Soderberg C, Stal P, Askling J, et al. Decreased survival of subjects with elevated liver function
tests during a 28-year follow-up. Hepatology 2010;51:595-602.
[4] Younossi ZM, Stepanova M, Rafiq N, et al. Pathologic criteria for nonalcoholic steatohepatitis:
interprotocol agreement and ability to predict liver-related mortality. Hepatology 2011;53:1874-
1882.
[5] Angulo P, Bugianesi E, Bjornsson ES, et al. Simple noninvasive systems predict long-term
outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology 2013;145:782-789
e784.
[6] Singh S, Allen AM, Wang Z, et al. Fibrosis Progression in Nonalcoholic Fatty Liver vs
Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis of Paired-Biopsy Studies.
Clin Gastroenterol Hepatol 2014; doi: 10.1016/j.cgh.2014.04.014.
[7] McPherson S, Hardy T, Henderson E, et al. Evidence of NAFLD progression from steatosis to
fibrosing-steatohepatitis using paired biopsies: implications for prognosis & clinical management.
J Hepatol 2014; doi: 10.1016/j.jhep.2014.11.034.
[8] Pais R, Charlotte F, Fedchuk L, et al. A systematic review of follow-up biopsies reveals disease
progression in patients with non-alcoholic fatty liver. J Hepatol 2013;59:550-556.
[9] Adams LA, Sanderson S, Lindor KD, et al. The histological course of nonalcoholic fatty liver
disease: a longitudinal study of 103 patients with sequential liver biopsies. J Hepatol 2005;42:132-
138.
[10] Anstee QM, Day CP.The genetics of NAFLD. Nat Rev Gastroenterol Hepatol 2013;10:645-655.
98 Postgraduate Course Syllabus • Metabolic Liver Disease
